Dargent D, Dumont M, Malinas Y
Sem Hop. 1983 Nov 3;59(40):2778-80.
Veralipride was given to 74 women with menopausal disorders. Clinical tolerance proved excellent and no abnormal variations were recorded in monitored biological parameters. Effectiveness is very satisfactory, all the more so that disorders are more specific and severe.
将维拉必利给予74名患有更年期紊乱的女性。临床耐受性良好,监测的生物学参数未记录到异常变化。疗效非常令人满意,尤其是当紊乱症状更具特异性且更严重时。